⌘K
Loading ticker…
State Street SPDR S&P Biotech ETF · Other
3m RS is unavailable, Market Stance is 47.8
As of 2026-08-24, State Street SPDR S&P Biotech ETF (XBI) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Other. Average daily range 2.6%, relative volume 1.01×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | Apellis Pharmaceuticals Inc | 1.83% | $136M |
| 2 | Alkermes PLC | 1.45% | $108M |
| 3 | MDGL | 1.38% | $103M |
| 4 | TGTX | 1.35% | $100M |
| 5 | INSM | 1.34% | $99M |
| 6 | SRRK | 1.30% | $96M |
| 7 | APGE | 1.28% | $95M |
| 8 | Protagonist Therapeutics Inc | 1.24% | $93M |
| 9 | SMMT | 1.24% | $92M |
| 10 | UTHR | 1.24% | $92M |
| 11 | PRAX | 1.24% | $92M |
| 12 | ARWR | 1.23% | $91M |
| 13 | COGT | 1.22% | $90M |
| 14 | BBIO | 1.19% | $88M |
| 15 | PTCT | 1.18% | $88M |
| 16 | CYTK | 1.18% | $88M |
| 17 | ALNY | 1.18% | $87M |
| 18 | EXEL | 1.17% | $87M |
| 19 | NUVL | 1.17% | $87M |
| 20 | KYMR | 1.16% | $87M |
| 21 | CGON | 1.16% | $86M |
| 22 | NTRA | 1.16% | $86M |
| 23 | NBIX | 1.16% | $86M |
| 24 | TWST | 1.16% | $86M |
| 25 | KRYS | 1.15% | $86M |
Showing 25 of 142 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
Daily range, ATR, beta, and the math for a 1-ADR stop.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XBI Jan avg: 2.56% median: 2.60% win: 75% σ: 3.76% n: 4 2022-04-12 → 2026-07-31 | XBI Feb avg: 0.90% median: -1.09% win: 50% σ: 8.64% n: 4 2022-04-12 → 2026-07-31 | XBI Mar avg: -4.97% median: -5.80% win: 25% σ: 4.15% n: 4 2022-04-12 → 2026-07-31 | XBI Apr avg: -3.19% median: 2.28% win: 60% σ: 9.29% n: 5 2022-04-12 → 2026-07-31 | XBI May avg: 0.53% median: 4.08% win: 60% σ: 5.75% n: 5 2022-04-12 → 2026-07-31 | XBI Jun avg: 6.33% median: 4.72% win: 80% σ: 6.15% n: 5 2022-04-12 → 2026-07-31 | XBI Jul avg: 2.72% median: 3.29% win: 80% σ: 6.29% n: 5 2022-04-12 → 2026-07-31 | XBI Aug avg: 1.06% median: 2.69% win: 75% σ: 4.86% n: 4 2022-04-12 → 2026-07-31 (current) | XBI Sep avg: -0.99% median: -3.83% win: 25% σ: 8.62% n: 4 2022-04-12 → 2026-07-31 | XBI Oct avg: 1.24% median: 0.89% win: 50% σ: 9.17% n: 4 2022-04-12 → 2026-07-31 | XBI Nov avg: 6.94% median: 5.97% win: 100% σ: 5.79% n: 4 2022-04-12 → 2026-07-31 | XBI Dec avg: 1.72% median: -0.87% win: 25% σ: 11.75% n: 4 2022-04-12 → 2026-07-31 |
Metrics matched 130 tickers across 142 holdings rows (86.3% of fund weight). Metrics as of 2026-08-24; holdings from the filing.
Holdings of XBI currently on TickerStance stock-RS leaderboards.
| 1.11% |
| 1Y RS |
| 27 |
| Stage 2 |